Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma-Reference-Cited by-同舟云学术

Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma

Published:2013-01-17 Issue:7 Volume:60 Page:E32-E34
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Cheung Irene Y.,Feng Yi,Cheung Nai-Kong V.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference9 articles.

1. The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report;Cohn;J Clin Oncol,2009

2. Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: Recommendations by the International Neuroblastoma Risk Group Task Force;Beiske;Br J Cancer,2009

3. Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma;Cheung;Clin Cancer Res,2008

4. Minimal disease monitoring by QRT-PCR: Guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials;Viprey;J Pathol,2008

5. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma;Stutterheim;J Clin Oncol,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Disease Burden;Pediatric Oncology;2024

2. Treatment of Rhabdomyosarcoma;Sarcomas of Bone and Soft Tissues in Children and Adolescents;2020-10-02

3. Immunotherapy for Neuroblastoma;Neuroblastoma;2019

4. Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells;Molecular and Cellular Biochemistry;2018-06-19

5. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?;Virchows Archiv;2018-02-21